Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study

Severe graft-versus-host disease (GVHD) is an often lethal complication of allogeneic hematopoietic stem cell transplantation (HSCT). The safety of clinical-grade mesenchymal stem cells (MSCs) has been validated, but mixed results have been obtained due to heterogeneity of the MSCs. In this phase I...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Hyeon Gyu, Yahng, Seung-Ah, Kim, Inho, Lee, Je-Hwan, Min, Chang-Ki, Kim, Jun Hyung, Kim, Chul Soo, Song, Sun U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722192/
https://www.ncbi.nlm.nih.gov/pubmed/26807024
http://dx.doi.org/10.4196/kjpp.2016.20.1.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722192/
https://www.ncbi.nlm.nih.gov/pubmed/26807024
http://dx.doi.org/10.4196/kjpp.2016.20.1.63

Ejemplares similares